Prices delayed by at least 15 minutes | Print


Oxford Biodynamics PLC (OBD)

ORD GBP0.01
Sell: 9.32p|Buy: 9.5p|Change: 0.01 (0.11%)

Open 

9.5p


Previous close 

9.49p


Trade high 

9.5p


Volume 

635,451


Year high 

52.00p


Year low 

9.00p


Dividend yield 

-


Market capitalisation 

£19.22 mn


P/E ratio 

-


ISIN 

GB00BD5H8572


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Oxford Biodynamics PLC- 2.16
FTSE AIM All Share+ 0.35
More...

Company profile

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202403:40:249.550347.79
28/03/202403:40:249.32111.03
28/03/202403:40:249.5201.90
28/03/202403:40:259.521,2542,019.13
28/03/202402:44:239.46542,6404,035.88

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.